Take Action Now!
This campaign is hosted by the Lung Cancer Action Network (LungCAN), a collaborative association of groups focused on lung cancer. We will protect your privacy, and keep you informed about this campaign and others. For technical support, contact Dusty Donaldson at lungcan@lungcan.org.
Recent Lung Cancer Advocates
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Carrie O.SpartaWI
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Allison H.New YorkNY
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Cindy A.MansfieldTX
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Linda S.Colorado SpringsCO
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Nancee R.Maryland HeightsMO
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Lily S.LakewoodCO
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Kayla L.PhoenixAZ
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Sam R.FanwoodNJ
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Pamela C.AndoverKS
As a constituent and someone who cares deeply about the future of lung cancer patients, I am counting on you to finish your work on fiscal year 2024 appropriations bills without further delay and support at least $25 million for the Department of Defense (DoD) Congressionally Directed Medical Research Program's (CDMRP) Lung Cancer Research Program as approved in the House’s FY24 Defense Appropriations Bill.
Thanks in part to Congress’ past investments in lung cancer research, significant advances have been made in lung cancer treatment, prevention, and early detection. However, lung cancer remains the leading cause of cancer mortality in the United States, and current therapies are not working for many patients. We urgently need more federal investments in research to make more progress for everyone impacted by lung cancer.
I join the Lung Cancer Action Network (LungCAN) in asking you to work in a bipartisan manner to pass a final FY 2024 spending package that includes $25 million for the Lung Cancer Research Program at the Department of Defense as approved in the House Defense Appropriations FY24 Bill last year.
The lung cancer community is counting on Congress to finalize FY 2024 appropriations by the current deadline and include this critical funding. Further delays will cause additional disruptions to the medical research that we need to find new treatments and diagnostics. Thank you for your consideration of my concerns. Melissa M.FayettevilleNC